BioSpace News Archive

Drug Development

Bradykinin Hypothesis of COVID-19 Offers Hope for Already-Approved Drugs

A group of researchers at Oak Ridge National Lab used the Summit supercomputer, the second-fastest in the world, to analyze data on more than 40,000 genes from 17,000 genetic samples related to COVID-19.

September 2, 2020
·
4 min read
·
Mark Terry
Celyad’s High Hopes for a Path Forward in Cancer Immunotherapy with CYAD-211

Celyad Oncology is at the forefront of cutting-edge immunotherapy and is hopeful of providing a new way forward for patients with relapsed/refractory multiple myeloma.

September 2, 2020
·
5 min read
·
Heather McKenzie
Business

CDC’s Recent Data Claim Causes Stir, Underlines Data and Societal Issues

Recently, the U.S. Centers for Disease Control and Prevention (CDC) made a regular data update on COVID-19 deaths. Unfortunately, the data, and how it was presented, was immediately misinterpreted.

September 2, 2020
·
7 min read
·
Mark Terry
Policy

House Committee Subpoenas AbbVie Over Drug Pricing for Humira, Imbruvica

Shares of AbbVie fell nearly 4% Tuesday following the issuance of a subpoena from the U.S. House Oversight and Reform Committee regarding an ongoing investigation into drug pricing.

September 2, 2020
·
3 min read
·
Alex Keown
Drug Development

Icelandic COVID-19 Study: Long-Lasting Antibodies and 0.3% Death Rate

There is new research out of Iceland that suggests the body’s immune response to COVID-19 lasts longer than other research has suggested.

September 2, 2020
·
3 min read
·
Mark Terry
Drug Development

At Least 4 Vaccine Candidates Backed by U.S. Government Predicted to Fail, Analytics Group Says

The U.S. government has financially backed the development of six different vaccine candidates aimed at the novel coronavirus. Although billions of dollars have been appropriated to the pandemic, at least four of those potential preventative treatments are predicted to fail in the clinic.

September 2, 2020
·
3 min read
·
Alex Keown
FDA

FDA Approves New HIV-1/HIV-2 Qualitative Test from Roche

This test will give healthcare providers a single result to confirm an HIV diagnosis with patients and differentiate between HIV-1 and HIV-2.

September 2, 2020
·
2 min read
·
Krystle Vermes
Business

Intercept Pharma to Cut 170 Employees in Wake of CRL for NASH Treatment

In an 8-K filing with the U.S. Securities and Exchange Commission, Intercept Pharmaceuticals said it will eliminate approximately 170 employees as part of an effort to streamline the company’s operations and reduce operating expenses.

September 2, 2020
·
2 min read
·
Alex Keown
Pharm Country

J&J Abandons Influenza A Treatment Program After Interim Analysis

Janssen Pharmaceutical of Johnson & Johnson made a strategic call to halt development of pimodivir, an antiviral treatment for influenza A.

September 2, 2020
·
3 min read
·
Mark Terry
Business

BioSpace Global Roundup, Sept. 3

Biopharma and life science companies from across the globe provide updates on their pipelines and businesses.

September 2, 2020
·
7 min read
·
Alex Keown